✦ LIBER ✦
PMS81 Cost-Effectiveness and Budget Impact of Certolizumab Pegol Against a Mix of Treatments in an Outcomes-Based Risk-Sharing Scheme in Finland
✍ Scribed by C. Asseburg; E.J. Soini; M. Taiha
- Book ID
- 119312282
- Publisher
- John Wiley and Sons
- Year
- 2012
- Tongue
- English
- Weight
- 60 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1098-3015
No coin nor oath required. For personal study only.